UCB
The Global Head of Commercial & Portfolio Management shapes global commercial and portfolio strategies for established medicines, connecting scientific evidence with patient and healthcare professional needs. This role involves balancing patient impact, sustainable growth, and investment across markets while translating insights into practical plans and fostering digital innovation. The position requires leading a high-performing team and collaborating with global, regional, and external partners to drive portfolio decisions and long-term value.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Head, Global/US Insights, Analytics and Forecasting
American Association of Physicists in Medicine
VP Head of Corporate Strategy
Takeda Pharmaceutical Company Limited
Senior Director, Global Commercial Development
Revolution Medicines
Commercial Director
Pernod Ricard
Director, Oncology Portfolio & Strategic Planning Lead
MSD
Head of Portfolio Growth
Pernod Ricard